- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A pharmacist complained GSK’s Seretide TORCH mortality exhibition panel highlighted a 16.5% risk reduction (p=0.096). PMCPA ruled it didn’t make non-significance clear…
Gilead’s Truvada BICOMBO leavepieces implied superiority and overstated lipid benefits without clinical context and without reflecting SPC safety info. Breaches of Clauses…
Anonymous complaint alleged Lilly-sponsored Heathrow meeting was a social get-together with music/cultural programme. Panel had due diligence concerns but found no evidence…
A Tabphyn MR journal ad claimed “Spend fewer pennies on the treatment of BPH”. PMCPA ruled it a hanging comparison (breach Clause…
A Versatis budget impact brochure compared “Total NHS cost” vs gabapentin but didn’t clearly define what costs were included. The PMCPA found…
A practice manager alleged a Teva rep was aggressive, demanded an immediate meeting and implied patients would suffer if advice wasn’t followed.…
A PCT pharmacist complained GSK promoted Rotarix to practice nurses (non-prescribers). PMCPA found it reasonable given nurses’ role in vaccine administration/ordering and…
A consultant challenged an MSD-commissioned market research survey that asked HCPs to nominate other specialists. Panel had concerns (transparency on questionnaire, £25…
PMCPA review of Vifor Fresenius clinical trial disclosure for Velphoro was found outwith the scope of the 2016 ABPI Code. No breach…
Complaint about omission of prescribing information/obligatory information. PMCPA concluded no breach and that the matter was outwith the scope of the ABPI…
Complaint about promotion of Brintellix. PMCPA recorded no breach because the matter was outwith the scope of the ABPI Code. No case…
Anonymous complaint about Lilly meeting sponsorship. PMCPA concluded the matter was outwith the scope of the ABPI Code (2012). No breach and…
AstraZeneca challenged a GSK leavepiece on the CONCEPT asthma study. The Panel ruled it misleading for omitting key context on average doses…
An Arimidex mailing used an envelope printed “Happy Birthday” with candles and no company identifiers. The PMCPA ruled it gave a misleading…
A Champix GP referral letter pad used by smoking cessation advisers/pharmacists was handed to patients to take to GPs. PMCPA found exaggerated…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.